Drug intelligence / Profile preview

BIOT-NFL

Development stage
Preclinical
Lead developer
GlioCure
Modality
Peptides
Administration
Intravenous
01

Overview

BIOT-NFL is a biotinylated peptide derived from the NFL-TBS.40-63 sequence, which corresponds to the tubulin-binding site of the light neurofilament chain (NFL). This research-grade compound is characterized by its ability to spontaneously self-assemble into stable nanofibers approximately 5 nm in width. BIOT-NFL serves as a potent cell-penetrating and targeting agent specifically designed to cross the blood-brain barrier (BBB) and the blood-brain tumor barrier (BBTB) to selectively target glioblastoma cells. In preclinical investigations, it is frequently utilized as a component of advanced drug delivery platforms, such as functionalized gold nanoparticles or liposomes, to facilitate the targeted delivery of chemotherapeutic agents like doxorubicin directly to brain tumor sites. This approach aims to enhance therapeutic efficacy through superior cellular uptake and induction of apoptosis while minimizing systemic off-target effects.

Other names
biotinylated NFL-TBS.40-63 peptidebiotinylated neurofilament-derived peptidebiotin-NFL-TBS.40-63
02

Targets

VIM (Vimentin)TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on BIOT-NFL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIOT-NFL.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call